Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00041600 · ClinicalTrials.gov registry record

Human Epilepsy Genetics--Neuronal Migration Disorders Study

A clinical trial of Epilepsy and Cognition Disorder, sponsored by Harvard University Faculty of Medicine.

Recruiting
Registry status
3,500
Enrollment target
1
Study location

NCT00041600 is a study of Epilepsy and Cognition Disorder that is actively recruiting participants, run by Harvard University Faculty of Medicine. The registered enrollment target is 3,500 participants, above the 931-participant average among 160 other Epilepsy trials with a reported enrollment target (276% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00041600, a study of Epilepsy and Cognition Disorder, is actively recruiting participants, sponsored by Harvard University Faculty of Medicine.

RECRUITING
Registry status
3,500 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to identify genes responsible for epilepsy, brain malformations and disorders of human cognition.

Conditions Studied

Epilepsy Cognition Disorder Brain Malformation Neuronal Migration Disorder

Study Locations (1)

Massachusetts

  • Boston Children's Hospital, Walsh Laboratory - Boston

Trial Details

FieldValue
Enrollment Target 3,500 participants
Start Date 1996-04
Est. Completion 2030-06

Sponsor

Harvard University Faculty of Medicine

9 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00041600

The ClinicalTrials.gov registry entry for NCT00041600 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 3,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 931-participant average among 160 other Epilepsy trials with a reported enrollment target (276% higher). The listed sponsor is Harvard University Faculty of Medicine, which has 9 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Epilepsy appearing as the primary indexed condition, and to 0 interventions.

NCT00041600 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00041600 about?

NCT00041600 is a clinical study titled "Human Epilepsy Genetics--Neuronal Migration Disorders Study". The purpose of this study is to identify genes responsible for epilepsy, brain malformations and disorders of human cognition.

What is the current status of trial NCT00041600?

This trial is currently recruiting. The enrollment target is 3,500 participants. The study started on 1996-04. Estimated completion is 2030-06.

What conditions does trial NCT00041600 study?

This clinical trial studies the following conditions: Epilepsy, Cognition Disorder, Brain Malformation, Neuronal Migration Disorder.

Who is sponsoring clinical trial NCT00041600?

This trial is sponsored by Harvard University Faculty of Medicine, which has 9 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00041600 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Epilepsy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Epilepsy

All registered trials for this condition

Cognition Disorder

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.